皮肤癌临床试验转型:灵活创新设计的潜力
Over the past 2 decades, innovations in trial design have significantly advanced the field of clinical research. Methodological developments, such as adaptive designs, basket trials, umbrella trials, and platform trials, along with technological advancements such as virtual studi…
要点
- 适应性设计、篮式/伞式/平台试验可在单一基础设施内回答多个研究问题。
- 虚拟研究等技术可提升可及性、效率与患者参与度。
- 创新设计可整合生物标志物或风险预测评分以优化患者选择。
核心结论
- 灵活创新的临床试验设计有潜力在有限患者和资金资源下优化黑色素瘤试验,并可扩展至其他非黑色素瘤皮肤癌试验。
研究设计与样本
- 本文为综述,聚焦黑色素瘤,概述已纳入创新特征的现有黑色素瘤临床试验及正在考虑的其他潜在研究。
主要发现
- 这些方法支持前瞻性计划的试验设计修改,并可在单一基础设施内回答多个研究问题。
- 虚拟研究等技术可提升可及性、效率与患者参与度。
- 这些设计可整合生物标志物信息或风险预测评分,通过更好的患者选择提升未来临床试验效力。
- 尽管具有吸引力,这些新方法的采用在不同治疗领域存在差异。
临床怎么用
- 在黑色素瘤临床试验中可考虑采用适应性设计、篮式/伞式/平台试验及虚拟研究等创新方法。
- 可利用生物标志物或风险预测评分优化患者选择,提升试验效力。
- 上述创新设计思路可扩展应用于非黑色素瘤皮肤癌试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past 2 decades, innovations in trial design have significantly advanced the field of clinical research. Methodological developments, such as adaptive designs, basket trials, umbrella trials, and platform trials, along with technological advancements such as virtual studies have proven effective in tackling complex research questions and managing resource constraints. These approaches enable prospectively planned modifications to trial designs and facilitate addressing multiple research questions within a single infrastructure, with technological advancements such as virtual studies enhancing accessibility, efficiency, and patient engagement. These designs can also integrate biomarker information or risk-prediction scores to enhance the efficacy of future clinical trials, through a better selection of patients. Despite the appealing flexibility of these new approaches, their adoption varies across different therapeutic domains. We explored the translation and relevance of these innovative approaches in skin cancer research with a focus on melanoma. An overview of existing melanoma clinical trials that incorporate innovative features as well as other potential studies currently under consideration are discussed. This paper highlights the potential of innovative approaches to optimize melanoma trials under the constraints of limited patient and financial resources. The presented ideas can easily be extended to other nonmelanoma skin cancer trials.
引用
- Puhr R, Ryan EG, Couturier DL, et al. Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs. J Invest Dermatol. 2025. PMID: 40545310. doi:10.1016/j.jid.2025.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。